Zhengye Biotechnology Holding Ltd is a company mainly engaged in the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. The Company markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The Company owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The Company also engages in vaccines for treating livestock. The Company mainly conducts its business in the domestic market. The Company mainly conducts its business in the domestic and overseas market.
Ticker SymbolZYBT
CompanyZhengye Biotechnology Holding Ltd
CEOHan (Aiden)
Websitehttps://www.jlzybio.com./
FAQs
What is the current price of Zhengye Biotechnology Holding Ltd (ZYBT)?
The current price of Zhengye Biotechnology Holding Ltd (ZYBT) is 1.850.
What is the symbol of Zhengye Biotechnology Holding Ltd?
The ticker symbol of Zhengye Biotechnology Holding Ltd is ZYBT.
What is the 52-week high of Zhengye Biotechnology Holding Ltd?
The 52-week high of Zhengye Biotechnology Holding Ltd is 14.300.
What is the 52-week low of Zhengye Biotechnology Holding Ltd?
The 52-week low of Zhengye Biotechnology Holding Ltd is 1.400.
What is the market capitalization of Zhengye Biotechnology Holding Ltd?
The market capitalization of Zhengye Biotechnology Holding Ltd is 87.26M.
What is the net income of Zhengye Biotechnology Holding Ltd?
The net income of Zhengye Biotechnology Holding Ltd is 11.31M.
Is Zhengye Biotechnology Holding Ltd (ZYBT) currently rated as Buy, Hold, or Sell?
According to analysts, Zhengye Biotechnology Holding Ltd (ZYBT) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Zhengye Biotechnology Holding Ltd (ZYBT)?
The Earnings Per Share (EPS TTM) of Zhengye Biotechnology Holding Ltd (ZYBT) is 0.034.